Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Health Professional Version
SECTIONS
- General Information About Ovarian Epithelial Cancer, Fallopian Tube Cancer (FTC), and Primary Peritoneal Cancer (PPC)
- Cellular Classification of Ovarian Epithelial Cancer, FTC, and PPC
- Stage Information for Ovarian Epithelial Cancer, FTC, and PPC
- Treatment Option Overview
- Early-Stage Ovarian Epithelial Cancer, FTC, and PPC Treatment
- Advanced-Stage Ovarian Epithelial Cancer, FTC, and PPC Treatment
- Recurrent or Persistent Ovarian Epithelial Cancer, FTC, and PPC Treatment
- Changes to This Summary (12/06/2018)
- About This PDQ Summary
- View All Sections
Changes to This Summary (12/06/2018)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Added Surgery followed by chemotherapy and poly(ADP-ribose) polymerase (PARP) inhibitors as a new subsection.
This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
.png)
No hay comentarios:
Publicar un comentario